Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 53, 1845-1852, April 15, 1993]
© 1993 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ling, Y.-H.
Right arrow Articles by Perez-Soler, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ling, Y.-H.
Right arrow Articles by Perez-Soler, R.

Apoptosis Induced by Anthracycline Antibiotics in P388 Parent and Multidrug-resistant Cells1

Yi-He Ling, Waldemar Priebe and Roman Perez-Soler2

Departments of Head, Neck, and Thoracic Medical Oncology [Y. H. L. R. P.] and Clinical Investigations [W. P.], The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

The effect of the topoisomerase II inhibitor doxorubicin and its noncross-resistant analogue annamycin on DNA degradation and programmed cell death was examined in murine leukemia P388 cells. P388 parental cells exposed to various concentrations of doxorubicin and annamycin for 24 h displayed dose-dependent DNA cleavage: at 1 µM, both doxorubicin and annamycin were effective in inducing DNA breakdown, but at 10 µM, the effect was markedly decreased or totally absent. In multidrug-resistant P388/Dox cells, doxorubicin did not cause DNA cleavage, while 10 µM annamycin had a significant effect. By agarose gel analysis, drug-induced DNA fragmentation showed the characteristic pattern of internucleosomal ladder. Morphologically, P388 cells treated with 1 µM doxorubicin or annamycin for 24 h showed a reduction in cell volume and condensation of nuclear structures. Similar changes were observed in P388/Dox cells exposed to 10 µM annamycin for 24 h but not in cells exposed to 10 µM doxorubicin. Time course studies demonstrated that DNA fragmentation was detected 12 h after incubation with 1 µM doxorubicin or annamycin, while loss of membrane integrity appeared at 24 h, thus indicating that DNA degradation was a preceding event. DNA fragmentaton caused by doxorubicin and annamycin was inhibited by the RNA synthesis inhibitor actinomycin D, the protein synthesis inhibitor cycloheximide, and the endonuclease inhibitor aurintricarboxylic acid. Drug-induced cell death was partially prevented by cycloheximide and aurintricarboxylic acid, thus suggesting that the apoptotic process caused by these drugs requires gene expression, synthesis of new proteins, and activation of endogenous nucleases. In contrast, DNA cleavage was not affected by incubating cells with 1 mM ethylene glycol-bis(2-aminoethyl ether)-N,N,N',N'-tetraacetic acid, thus indicating that intracellular calcium depletion does not affect anthracycline-induced apoptosis. The results obtained demonstrate that the cell killing effect of anthracyclines is mediated, at least in part, by the induction of apoptosis.

1 Supported in part by NIH Grant CA50270 and Argus Pharmaceutical, Inc.

2 To whom requests for reprints should be addressed, at Department of Head, Neck, and Thoracic Medical Oncology, Box 80, 1515 Holcombe Boulevard, Houston, TX 77030.

Received 10/ 7/92. Accepted 1/18/93.




This article has been cited by other articles:


Home page
BloodHome page
G. Gausdal, B. T. Gjertsen, E. McCormack, P. Van Damme, R. Hovland, C. Krakstad, O. Bruserud, K. Gevaert, J. Vandekerckhove, and S. O. Doskeland
Abolition of stress-induced protein synthesis sensitizes leukemia cells to anthracycline-induced death
Blood, March 1, 2008; 111(5): 2866 - 2877.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
F. Hassan, S. Islam, M. M. Mu, H. Ito, N. Koide, I. Mori, T. Yoshida, and T. Yokochi
Lipopolysaccharide Prevents Doxorubicin-Induced Apoptosis in RAW 264.7 Macrophage Cells by Inhibiting p53 Activation
Mol. Cancer Res., July 1, 2005; 3(7): 373 - 379.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
A. V. Trevino, B. A. Woynarowska, T. S. Herman, W. Priebe, and J. M. Woynarowski
Enhanced topoisomerase II targeting by annamycin and related 4-demethoxy anthracycline analogues
Mol. Cancer Ther., November 1, 2004; 3(11): 1403 - 1410.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
J. Li, W. Li, J. Su, W. Liu, B. T. Altura, and B. M. Altura
Peroxynitrite Induces Apoptosis in Rat Aortic Smooth Muscle Cells: Possible Relation to Vascular Diseases
Experimental Biology and Medicine, March 1, 2004; 229(3): 264 - 269.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. W. Elmore, C. W. Rehder, X. Di, P. A. McChesney, C. K. Jackson-Cook, D. A. Gewirtz, and S. E. Holt
Adriamycin-induced Senescence in Breast Tumor Cells Involves Functional p53 and Telomere Dysfunction
J. Biol. Chem., September 13, 2002; 277(38): 35509 - 35515.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
Y.-H. Ling, L. Liebes, B. Ng, M. Buckley, P. J. Elliott, J. Adams, J.-D. Jiang, F. M. Muggia, and R. Perez-Soler
PS-341, a Novel Proteasome Inhibitor, Induces Bcl-2 Phosphorylation and Cleavage in Association with G2-M Phase Arrest and Apoptosis
Mol. Cancer Ther., August 1, 2002; 1(10): 841 - 849.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Z. Carter, M. Milella, D. C. Altieri, and M. Andreeff
Cytokine-regulated expression of survivin in myeloid leukemia
Blood, May 1, 2001; 97(9): 2784 - 2790.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y.-H. Ling, Y. Zhong, and R. Perez-Soler
Disruption of Cell Adhesion and Caspase-Mediated Proteolysis of {beta}- and {gamma}-Catenins and APC Protein in Paclitaxel-Induced Apoptosis
Mol. Pharmacol., March 1, 2001; 59(3): 593 - 603.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
O. J. Arola, A. Saraste, K. Pulkki, M. Kallajoki, M. Parvinen, and L.-M. Voipio-Pulkki
Acute Doxorubicin Cardiotoxicity Involves Cardiomyocyte Apoptosis
Cancer Res., April 1, 2000; 60(7): 1789 - 1792.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
N. J. Donato, M. Perez, H. Kang, Z. H. Siddik, Y.-H. Ling, and R. Perez-Soler
EGF Receptor and p21WAF1 Expression are Reciprocally Altered as ME-180 Cervical Carcinoma Cells Progress from High to Low Cisplatin Sensitivity
Clin. Cancer Res., January 1, 2000; 6(1): 193 - 202.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
E. Delpy, S. N Hatem, N. Andrieu, C. de Vaumas, M. Henaff, C. Rucker-Martin, J.-P. Jaffrezou, G. Laurent, T. Levade, and J.-J. Mercadier
Doxorubicin induces slow ceramide accumulation and late apoptosis in cultured adult rat ventricular myocytes
Cardiovasc Res, August 1, 1999; 43(2): 398 - 407.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-H. Ling, C. Tornos, and R. Perez-Soler
Phosphorylation of Bcl-2 Is a Marker of M Phase Events and Not a Determinant of Apoptosis
J. Biol. Chem., July 24, 1998; 273(30): 18984 - 18991.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
N. Mizuno, H. Yoshitomi, H. Ishida, H. Kuromi, J. Kawaki, Y. Seino, and S. Seino
Altered bcl-2 and bax Expression and Intracellular Ca2+ Signaling in Apoptosis of Pancreatic Cells and the Impairment of Glucose-Induced Insulin Secretion
Endocrinology, March 1, 1998; 139(3): 1429 - 1439.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Los, I. Herr, C. Friesen, S. Fulda, K. Schulze-Osthoff, and K.-M. Debatin
Cross-Resistance of CD95- and Drug-Induced Apoptosis as a Consequence of Deficient Activation of Caspases (ICE/Ced-3 Proteases)
Blood, October 15, 1997; 90(8): 3118 - 3129.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1993 by the American Association for Cancer Research.